Evidence map›Paper›PMID 33458319›Full record

ArticlePhysics and imaging in radiation oncology2020

Exploration of clinical preferences in treatment planning of radiotherapy for prostate cancer using Pareto fronts and clinical grading analysis.

A Kyroudi, K Petersson, E Ozsahin, J Bourhis, F Bochud, R Moeckli

Open access · goldAbstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

A KyroudiInstitute of Radiation Physics, Lausanne University Hospital, Rue du Grand-Pré 1, CH 1007 Lausanne, Switzerland.
K PeterssonInstitute of Radiation Physics, Lausanne University Hospital, Rue du Grand-Pré 1, CH 1007 Lausanne, Switzerland.
E OzsahinDepartment of Radiation Oncology, Lausanne University Hospital, Rue du Bugnon 46, CH 1011 Lausanne, Switzerland.
J BourhisDepartment of Radiation Oncology, Lausanne University Hospital, Rue du Bugnon 46, CH 1011 Lausanne, Switzerland.
F BochudInstitute of Radiation Physics, Lausanne University Hospital, Rue du Grand-Pré 1, CH 1007 Lausanne, Switzerland.
R MoeckliInstitute of Radiation Physics, Lausanne University Hospital, Rue du Grand-Pré 1, CH 1007 Lausanne, Switzerland.
Institute of Radiation PhysicsUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRadiotherapy treatment planning is a multi-criteria problem. Any optimization of the process produces a set of mathematically optimal solutions. These optimal plans are considered mathematically equal, but they differ in terms of the trade-offs involved. Since the various objectives are conflicting, the choice of the best plan for treatment is dependent on the preferences of the radiation oncologists or the medical physicists (decision makers).We defined a clinically relevant area on a prostate Pareto front which better represented clinical preferences and determined if there were differences among radiation oncologists and medical physicists. METHODS AND MATERIALS: Pareto fronts of five localized prostate cancer patients were used to analyze and visualize the trade-off between the rectum sparing and the PTV under-dosage. Clinical preferences were evaluated with Clinical Grading Analysis by asking nine radiation oncologists and ten medical physicists to rate pairs of plans presented side by side. A choice of the optimal plan on the Pareto front was made by all decision makers.

resultsThe plans in the central region of the Pareto front (1-4% PTV under-dosage) received the best evaluations. Radiation oncologists preferred the organ at risk (OAR) sparing region (2.5-4% PTV under-dosage) while medical physicists preferred better PTV coverage (1-2.5% PTV under-dosage). When the Pareto fronts were additionally presented to the decisions makers they systematically chose the plan in the trade-off region (0.5-1% PTV under-dosage).

conclusionWe determined a specific region on the Pareto front preferred by the radiation oncologists and medical physicists and found a difference between them.

Indexed as

CGAClinical decision makingPareto frontsProstateTrade-offs

Identifiers

PMID33458319
PMCPMC7807626
OpenAlexW3035150991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.